NEFL and Brain atrophy: Serum NfL is elevated in FTLD,17 and in symptomatic carriers of f-FTLD–causing mutations, concentrations correlate with brain atrophy.18 We tested the hypothesis that plasma NfL could identify asymptomatic f-FTLD mutation carriers at high risk of progression to symptomatic disease.